December 14, 2024 02:39 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess

SII to supply 90 to 100 million Covishield doses in June: Report

May 31, 2021, at 03:28 am

Pune/IBNS: The Serum Institute of India (SII) has said it will be able to manufacture and supply 90 to 100 million doses of Covishield in June, media reports said.

'Never exported vaccines at the cost of people of India': Adar Poonawalla

May 19, 2021, at 01:29 am

Pune/IBNS: Adar Poonawalla, CEO of Serum Institute of India (SII), the manufacturer of Covishield, on Tuesday said that his company has "never exported vaccines at the cost of the people of India".

Good scientific decision: Adar Poonawalla on increase in gap between Covishield doses

May 14, 2021, at 01:05 am

New Delhi/IBNS: Adar Poonawalla, the CEO of Serum Institute of India (SII) that manufactures anti-Covid-19 vaccine Covishield, has welcomed the central government's decision to increase the gap between the first and second doses of the vaccine to 12-16 weeks.

'Believe Rs 3,000 cr govt aid will reach us soon, didn't wait but borrowed': SII CEO Adar Poonawalla

Apr 22, 2021, at 06:42 am

Mumbai/IBNS: Serum Institute of India (SII) has borrowed money from banks to ramp up the production of Covishield instead of waiting for the government's aid of Rs 3,000 crore to arrive.

Serum Institute seeks financial assistance from govt to boost capacity

Apr 08, 2021, at 04:00 am

New Delhi/IBNS: Adar Poonawalla, the CEO of world's largest vaccine manufacturer Serum Institute of India (SII), has told NDTV it needs Rs 3,000 crore in assistance from the Indian government to expand its production capacity which is currently "very stretched" in wake of the export restrictions imposed by the government last month.

Madras HC issues notice to Centre on plea to declare Covishield 'unsafe'

Feb 20, 2021, at 01:53 am

Chennai/IBNS: The Madras High Court has issued a notice to the Centre over a petition to declare India's indigenous coronavirus vaccine -'Covishield'- developed by Pune-based Serum Institute as "unsafe".

Fire breaks out again at Serum Institute's under-construction building hours after 5 die

Jan 22, 2021, at 04:10 am

Pune/IBNS: A second fire broke out at the Serum Institute of India (SII)'s under-construction building after the massive blaze that claimed five lives at the vaccine developer's Pune facility on Thursday.

Pune: 5 killed in fire at Serum Institute's under-construction facility

Jan 22, 2021, at 12:00 am

Pune/IBNS: At least five people have been killed in the fire which broke out at an under-construction facility of India's biotechnology and pharmaceuticals company Serum Institute of India (SII) here on Thursday.

Fire breaks out at Serum Institute's under-construction facility in Pune

Jan 21, 2021, at 10:47 pm

Pune/IBNS: A fire broke out at an under-construction facility of India's biotechnology and pharmaceuticals company Serum Institute of India (SII) here on Thursday.